GRCLF yields 3.31% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, GRCLF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRCLF + MRK for your $10,000?
GrainCorp Limited operates as an agribusiness and processing company in Australasia, Asia, North America, Europe, the Middle East, North Africa, and internationally. It operates through two segments, Agribusiness and Processing. The company handles, markets, and trades in wheat, barley, sorghum, corn, oilseeds, pulses, organics, canola, chickpeas, and specialty commodities; handles, processes, stores, and transports grains and oilseeds; refines, bleaches, deodorizes, and blends edible fats and oil products; and crushes, processes, manufactures, and distributes edible oils. It also manufactures and supplies molasses-based feed supplements and vegetable oil to enhance farm productivity in beef cattle, sheep, dairy cattle, and other domestic livestock; and crude degummed canola oils, refined bleached canola oils, and canola meal. In addition, the company provides blended and single oils, infant nutrition, bakery margarines, spreads, and shortening; crushes oilseed products are used in cooking oils, spreads and shortenings, prepared foods, meal for dairy, poultry and livestock, cosmetics and lubricants, fuels, and other industrial applications; and operates seven bulk port terminals. Further it is involved in the procurement, shipping, accreditation, and value-added supply of tallow and used cooking oil, which are used for renewable energy feedstock and industrial applications, as well as vegetable oils; and the provision of logistics services. GrainCorp Limited was founded in 1916 and is headquartered in Sydney, Australia.
Full GRCLF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.